These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 15640327)

  • 1. Cardiopulmonary effects of iloprost in experimental acute lung injury.
    Dembinski R; Brackhahn W; Henzler D; Rott A; Bensberg R; Kuhlen R; Rossaint R
    Eur Respir J; 2005 Jan; 25(1):81-7. PubMed ID: 15640327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung vasodilatory response to inhaled iloprost in experimental pulmonary hypertension: amplification by different type phosphodiesterase inhibitors.
    Schermuly RT; Inholte C; Ghofrani HA; Gall H; Weissmann N; Weidenbach A; Seeger W; Grimminger F
    Respir Res; 2005 Jul; 6(1):76. PubMed ID: 16033645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to pulmonary fibrosis].
    Olschewski H; Ghofrani HA; Walmrath D; Schermuly R; Temmesfeld-Wollbrück B; Grimminger F; Seeger W
    Pneumologie; 2000 Mar; 54(3):133-42. PubMed ID: 10783653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhaled iloprost controls pulmonary hypertension after cardiopulmonary bypass.
    Theodoraki K; Rellia P; Thanopoulos A; Tsourelis L; Zarkalis D; Sfyrakis P; Antoniou T
    Can J Anaesth; 2002 Nov; 49(9):963-7. PubMed ID: 12419726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iloprost improves gas exchange and exercise tolerance in patients with pulmonary hypertension and chronic obstructive pulmonary disease.
    Dernaika TA; Beavin M; Kinasewitz GT
    Respiration; 2010; 79(5):377-82. PubMed ID: 19786728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Ideal PEEP" is superior to high dose partial liquid ventilation with low PEEP in experimental acute lung injury.
    Wolf S; Lohbrunner H; Busch T; Deja M; Weber-Carstens S; Donaubauer B; Sterner-Kock A; Kaisers U
    Intensive Care Med; 2001 Dec; 27(12):1937-48. PubMed ID: 11797031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of inhaled aerosolized iloprost and inhaled NO on pulmonary circulation and edema formation in ovine lung injury.
    Hucklenbruch C; Hinder F; Berger C; Ertmer C; Lange M; Westphal M; Van Aken H; Ellger B; Dirk Stubbe H
    Shock; 2008 Jul; 30(1):75-80. PubMed ID: 18562927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coaerosolization of phosphodiesterase inhibitors markedly enhances the pulmonary vasodilatory response to inhaled iloprost in experimental pulmonary hypertension. Maintenance of lung selectivity.
    Schermuly RT; Krupnik E; Tenor H; Schudt C; Weissmann N; Rose F; Grimminger F; Seeger W; Walmrath D; Ghofrani HA
    Am J Respir Crit Care Med; 2001 Nov; 164(9):1694-700. PubMed ID: 11719312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous tezosentan improves gas exchange and hemodynamics in acute lung injury secondary to meconium aspiration.
    Geiger R; Kleinsasser A; Meier S; Neu N; Pajk W; Fischer V; Treml B; Stein JI; Loeckinger A
    Intensive Care Med; 2008 Feb; 34(2):368-76. PubMed ID: 17898997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The acute effects of inhaled iloprost on hemodynamics and oxygenation in chronic thromboembolic pulmonary hypertension].
    Luo L; Yang YH; Cui N; Xie WM; Zhai ZG; Ma ZH; Wang C
    Zhonghua Yi Xue Za Zhi; 2009 Aug; 89(30):2103-5. PubMed ID: 20058612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhaled iloprost to control residual pulmonary hypertension following pulmonary endarterectomy.
    Kramm T; Eberle B; Guth S; Mayer E
    Eur J Cardiothorac Surg; 2005 Dec; 28(6):882-8. PubMed ID: 16242948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiremodeling effects of iloprost and the dual-selective phosphodiesterase 3/4 inhibitor tolafentrine in chronic experimental pulmonary hypertension.
    Schermuly RT; Kreisselmeier KP; Ghofrani HA; Samidurai A; Pullamsetti S; Weissmann N; Schudt C; Ermert L; Seeger W; Grimminger F
    Circ Res; 2004 Apr; 94(8):1101-8. PubMed ID: 15031263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Favorable effects of inhaled treprostinil in severe pulmonary hypertension: results from randomized controlled pilot studies.
    Voswinckel R; Enke B; Reichenberger F; Kohstall M; Kreckel A; Krick S; Gall H; Gessler T; Schmehl T; Ghofrani HA; Schermuly RT; Grimminger F; Rubin LJ; Seeger W; Olschewski H
    J Am Coll Cardiol; 2006 Oct; 48(8):1672-81. PubMed ID: 17045906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of inhaled prostacyclin in combination with almitrine on ventilation-perfusion distributions in experimental lung injury.
    Dembinski R; Max M; López F; Kuhlen R; Kurth R; Rossaint R
    Anesthesiology; 2001 Mar; 94(3):461-7. PubMed ID: 11374607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhaled aerosolized prostaglandin E1, pulmonary hemodynamics, and oxygenation during lung transplantation.
    Della Rocca G; Coccia C; Pompei L; Costa MG; Di Marco P; Pietropaoli P
    Minerva Anestesiol; 2008 Nov; 74(11):627-33. PubMed ID: 18971891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulating the pulmonary circulation: an update.
    Dembinski R; Henzler D; Rossaint R
    Minerva Anestesiol; 2004 Apr; 70(4):239-43. PubMed ID: 15173703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose inhalation of an endothelin-A receptor antagonist in experimental acute lung injury: ET-1 plasma concentration and pulmonary inflammation.
    Donaubauer B; Busch T; Lachmann R; Deja M; Petersen B; Francis R; Träger A; Ebsen M; Boemke W; Kaisers U
    Exp Biol Med (Maywood); 2006 Jun; 231(6):960-6. PubMed ID: 16741031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhaled tezosentan reduces pulmonary hypertension in endotoxin-induced lung injury.
    Persson BP; Rossi P; Weitzberg E; Oldner A
    Shock; 2009 Oct; 32(4):427-34. PubMed ID: 19197226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute and long-term effects of inhaled iloprost in portopulmonary hypertension.
    Melgosa MT; Ricci GL; García-Pagan JC; Blanco I; Escribano P; Abraldes JG; Roca J; Bosch J; Barberà JA
    Liver Transpl; 2010 Mar; 16(3):348-56. PubMed ID: 20209595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhaled nitric oxide versus aerosolized iloprost for the treatment of pulmonary hypertension with left heart disease.
    Yin N; Kaestle S; Yin J; Hentschel T; Pries AR; Kuppe H; Kuebler WM
    Crit Care Med; 2009 Mar; 37(3):980-6. PubMed ID: 19237907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.